| Trial Identifier: | D133HR00027 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT05905939 |
| Start Date: | May 2023 |
| Primary Completion Date: | June 2024 |
| Study Completion Date: | June 2024 |
| Condition: | Breast Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Russia | Arkhangelsk, Russia |
| Russia | Barnaul, Russia |
| Russia | Belgorod, Russia |
| Russia | Chelyabinsk, Russia |
| Russia | Grozniy, Russia |
| Russia | Irkutsk, Russia |
| Russia | Kaluga, Russia |
| Russia | Kchabarovsk, Russia |
| Russia | Khanty-Mansiysk, Russia |
| Russia | Kommunarka, Russia |
| Russia | Kostroma, Russia |
| Russia | Krasnodar, Russia |
| Russia | Krasnoyarsk, Russia |
| Russia | Moscow, Russia |
| Russia | N.Novgorod, Russia |
| Russia | Nalchik, Russia |
| Russia | Novosibirsk, Russia |
| Russia | Noyabrsk, Russia |
| Russia | Perm, Russia |
| Russia | Pyatigorsk, Russia |
| Russia | Ryazan, Russia |
| Russia | Sakhalin, Russia |
| Russia | Sochi, Russia |
| Russia | St.Petersburg, Russia |
| Russia | Surgut, Russia |
| Russia | Tomsk, Russia |
| Russia | Tver, Russia |
| Russia | Ufa, Russia |
| Russia | Ulan-Ude, Russia |
| Russia | Vladivostok, Russia |
| Russia | Volgograd, Russia |
| Russia | Yaroslavl, Russia |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company